R. Leavitt

REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia

M. Maris, S. Dakhil, F. Ravandi, 2014, British journal of haematology.

Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma

T. Mok, W. Yeo, P. Johnson, 2001, Cancer.

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

M. Maris, F. Ravandi, J. Karp, 2015, Haematologica.

A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel

J. Werner, A. Dietz, G. Dyckhoff, 2002, British Journal of Cancer.

Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: A multicenter, randomized, double‐blind, phase III study in North America

D. Castro, H. Garewal, E. Orenberg, 2003, Head & neck.

Decitabine improves patient outcomes in myelodysplastic syndromes

John M Bennett, J. Issa, Lanlan Shen, 2006, Cancer.

Unusual cytogenetic findings in two patients with t(4;11) acute leukemia

J. Testa, S. Misawa, R. Leavitt, 1986, International journal of cancer.

The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck.

D. Castro, J. Werner, H. Garewal, 2002, Archives of otolaryngology--head & neck surgery.